Market Overview
From USD 2.35 billion in 2020, the HIV diagnostic market Forecast is expected to grow at a CAGR of 10.5 percent to USD 3.88 billion by 2030. The market is predicted to develop due to factors like the rising global prevalence of HIV/AIDS, the rising number of blood transfusions and blood donations, the advantages provided by point-of-care tools and kits, and increased government initiatives. The study's base year was 2021, as well as the projection was made for the years 2020 through 2030. COVID-19 appears to have a significant impact on the HIV diagnostics market.
The human immunodeficiency virus (HIV) targets the human body's immune system. Hiv - Infected people can receive antiretroviral medication and live a long and healthy life. The firm's demand will be fueled by the availability of several HIV diagnostic tests.
Market Segmentation
By Product
Consumables: The need for consumable products for each test is the fastest increasing segment of the HIV diagnostics industry.
Instruments: This is the largest segment in the HIV diagnostics industry by product.
Software and Services: As more academics entered this new field of study, the demand for power tools and software grew, resulting in the growth of such tools.
By Test Type
- Antibody Tests
- HIV-1 Screening Test
- HIV-2 Group O Diagnostic Tests
- HIV-1 Antibody Confirmatory Tests
Consumables: The need for consumable products for each test is the fastest increasing segment of the HIV diagnostics industry.
Instruments: This is the largest segment in the HIV diagnostics industry by product.
Software and Services: As more academics entered this new field of study, the demand for power tools and software grew, resulting in the growth of such tools.
By End-User
Diagnostic Laboratories: When it comes to end consumers, diagnostic labs are the fastest increasing segment. There are a lot of diagnostic centers dedicated to HIV infection diagnosis.
Hospitals: Hospitals held the highest share of the HIV diagnostics market by end-user and are predicted to grow at a good CAGR over the forecast period.
Blood Banks: The growing number of surgical operations necessitates the use of blood.
Others- HIV/AIDS campaigns and research institutes are among the other end users.
Regional Classification
Americas- In the HIV diagnostics market, the Americas has the biggest market share. HIV/AIDS is regarded as one of the world's most persistent crises in the United States and other nations.
Europe- Europe is the second-largest marketplace for HIV diagnostics after the United States.
Asia-Pacific: In the HIV diagnostics market, the Asia-Pacific area is anticipated to grow at the quickest rate.
Middle East Africa: Due to a lack of healthcare infrastructure, lack of knowledge, and insufficient resources in this area, the Middle East Africa has the smallest market share.
Industry News
In developing nations, the prevalence of HIV is increasing, and HIV diagnostic tests are critical for proper diagnosis and treatment of an individual's health. HIV continues to be an issue in many African nations and other developing countries throughout the world. As a result, the rising HIV prevalence in these nations will drive up demand for HIV tests. Low penetration in the developing world, on the other hand, may limit the market to some extent.
By 2027, the antibody test segment is expected to rise at a rate of 1.3 percent. When the immune system is exposed to viruses like HIV, antibodies are formed, and these tests detect HIV antibodies in saliva or blood.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/hiv-diagnostics-market-9757
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
